Xeris Pharmaceuticals | Der Umsatz



Sales Veränderung Datum
Adcock Ingram Holdings ZAR 4.71B 188.47M 2024-12
Celltrion KRW 961.51B 119.6B 2025-06
Cspc Pharmaceutical CNY 7.01B 691.61M 2025-03
Dianthus Therapeutics USD 193K 1.13M 2025-06
Divis Laboratories Ltd 24.1B 1.75B 2025-06
Eli Lilly USD 15.56B 2.83B 2025-06
Kangmei Pharma CNY 1.27B 32.4M 2025-06
Knight Therapeutics CAD 92.26M 3.31M 2024-09
Laboratorios Farma 159.7M 274.71M 2025-06
Malin Corporation EUR 19.2M 2.6M 2020-12
Medical Developments International AUD 7.54M 0 2023-12
Neuren Pharmaceuticals AUD 194.1M 163.93M 2024-12
Organigram Holdings CAD 70.79M 28.06M 2025-06
Pacira USD 181.1M 12.18M 2025-06
Perrigo USD 1.06B 20M 2025-06
Pharma Mar EUR 56.39M 17.49M 2025-06
Qiagen NV USD 533.54M 108.24M 2025-06
Sartorius EUR 884.3M 1.3M 2025-06
Sino Biopharmaceutical CNY 17.57B 1.7B 2025-06
Supernus Pharmaceuticals USD 165.5M 15.7M 2025-06
Tilray USD 308.01M 43.78M 2025-06
Zhangzhou Pientzehuang Pharmaceutical 2.24B 902.99M 2025-06


Xeris Pharmaceuticals Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.